The CancerAid app provides support and education to cancer patients and families through a community platform, health coaching and clinician- connected care.
A targeted, smart trigger system to help nurses identify early signs of deterioration and potential falls to help them spend time with patients who need them most.
Health Delivered is a dietary management platform designed to tackle the growing rates of obesity, diabetes and other chronic health issues.
Kesem Health is developing the iUFlow, a home urination activity monitoring solution that promotes early, accurate diagnosis and monitoring of lower urinary tract symptoms.
Ingestible pill sensor which provides real time gas information for gut health diagnosis and management
Improves medication dosing accuracy and patient outcomes through real-time medication dosing decision support
A digital intervention in medication adherence which forms positive habits through fun games and memorable rewards
Hospital standard epilepsy monitoring and diagnosis delivered digitally in the home
An app to help manage children’s food allergies and to share their ASCIA action plan with carers.
SkinView is pursuing partnering on a point of care solution for diagnosis of skin cancer and skin lesions which transforms a smartphone into a dermatoscope.
Cohort Company Outcomes Reported to ANDHealth (as at June 30 2019).
2017 Cohort Onboarded October 2017 | 2018 Cohort onboarded September 2018.
"The ANDHealth process is unique, as unlike many accelerators and grants which focus on very early stage ideas, ANDHealth supports innovative companies like DoseMe, to expand into other marketplaces and sustain that growth. Developing a strategy for DoseMe in partnership with a talented set of ANDHealth advisors, with expertise ranging from clinical research through to pharmaceutical marketing, is of distinct value as we scale our operations."
“It has been a great experience being part of the ANDHealth+ program. The support and insights from our expert panel and the ANDHealth team has helped open doors and allowed us to focus our business strategy and path to market. Being able to network with the other teams in the Program has given us a broad exposure to other challenges and commercial hurdles a digital health company may face and ways in which to tackle these.”
ANDHealth+ was a critical supporter for us as we successfully started commercialising our unique product. The tailored assistance given ranged from funding support for a real-world trial with an ANDHealth+ partner, strategic regulations and market-entry advice, plus a sounding-board of experienced med-tech professionals.
"From the ANDHelath+ program we have been able to finalise some commercial priorities for future planning and company direction. We have been able to find the right expertise from internationally recognised leaders in broad areas from global regulatory strategies to clinical trial design."
The members on our panel were extremely diverse in their backgrounds, this diversity of industry representatives allowed for a very comprehensive 360degree business review and supply of advice. All members had extensive industry experience, so any advice and guidance provided was greatly valued – this experience also enabled us to leverage of a vast number of networks across the industry. We feel we have established an excellent rapport with all members of our panel, and will look to continue to maintain in contact.
“The support and insights from our expert panel and the ANDHealth team has helped open doors and allowed us to focus our business strategy and path to market. Access to industry experts and the other teams in the Program has given us a broad exposure to other challenges and commercial hurdles a digital health company may face and ways in which to tackle these.”
Sign up to our mailing list to keep up to date with ANDHealth